Cognimark

Dementia Detection in Seconds

Weston, Massachusetts, US

Precision Medicine/DiagnosticsBootstrapped

Operating as Cognimark, a neurology AI platform for dementia detection

Cognimark hero image

Shareable draft

Check out Cognimark on @MedStartr Today Operating as Cognimark, a neurology AI platform for dementia detection. #AlzheimerSDiseaseDementia #PrecisionMedicineDiagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/no6thy15aFc

Get Involved in Cognimark

How We Help

Problem Statement

Cognimark aims to improve dementia assessment and clinical trial screening by instantly analyzing routine healthcare data from Electronic Health Records (EHRs) to generate attributable cognitive scores across various dementia types and stages.

Core Technology

neurology AI platform

Key Differentiators

Instantly analyzes routine healthcare data from Electronic Health Records (EHRs); Generates attributable cognitive scores across various dementia types and stages; Improves dementia assessment and clinical trial screening

Clinical Focus

Neurology; Cognitive Health

Company Info

Business Model: B2B
Website: cognimark.ai

Disease Areas

Alzheimer's & Dementia

Technologies

Machine LearningEHRAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Nature Medicine (2024): Differential diagnosis model with 51,269 participants; Nature Communications (2025): AI-guided stratification showing 46% slowing of cognitive decline in AD trials

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Cognimark?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.